Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
The early completion of patient enrollment in this pivotal study may accelerate data analysis and potential regulatory milestones, potentially impacti...
Read Full Article →